(Q35215452)

English

A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization

scientific article published on November 1, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

immunosuppression

1 reference

based on heuristic

inferred from title

neovascularization

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

10

object named as

Emily Chew

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Robert B. Nussenblatt

1

object named as

Robert B Nussenblatt

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

3

object named as

H Nida Sen

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Keith Wroblewski

7

object named as

Keith Wroblewski

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

14

object named as

Frederick Ferris

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20847709

14 July 2024

author name string

Gordon Byrnes

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Steven Yeh

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Lisa Faia

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Catherine Meyerle

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Zhuqing Li

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Baoying Liu

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Penelope Friedman

12

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Fred Gill

13

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

H. Nida Sen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20847709

14 July 2024

Patti R. Sherry

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20847709

14 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20847709

14 July 2024

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://europepmc.org/articles/pmc3174007?pdf=render

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20847709

14 July 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20847709/pdf/?tool=EBI

Portable Document Format

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20847709

14 July 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20847709/?tool=EBI

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20847709

14 July 2024

https://europepmc.org/articles/PMC3174007

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20847709

14 July 2024

https://europepmc.org/articles/PMC3174007?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20847709

14 July 2024

https://doi.org/10.1097/iae.0b013e3181e7978e

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20847709

14 July 2024

https://journals.lww.com/10.1097/IAE.0b013e3181e7978e

1 reference

10.1097/IAE.0B013E3181E7978E

https://api.crossref.org/works/10.1097/IAE.0B013E3181E7978E

14 July 2024

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1579-1587

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Age-related macular degeneration: an immunologically driven disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Molecular pathology of age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Oxidative damage-induced inflammation initiates age-related macular degeneration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Age-related macular degeneration and the immune response: implications for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Circulating anti-retinal antibodies as immune markers in age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Systemic rapamycin inhibits retinal and choroidal neovascularization in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Prevalence of age-related macular degeneration in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Sirolimus: its discovery, biological properties, and mechanism of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

A role for local inflammation in the formation of drusen in the aging eye.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Immunological and aetiological aspects of macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Macrophages related to Bruch's membrane in age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

28 July 2018

Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

26 September 2018

Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

26 September 2018

PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

26 September 2018

Regression of neovascular age-related macular degeneration following infliximab therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

26 September 2018

Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

26 September 2018

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174007

26 September 2018

Senile macular degeneration: the involvement of immunocompetent cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20847709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies to retinal astrocytes associated with age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20847709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20847709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20847709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of multifocal choroiditis associated choroidal neovascularization with sirolimus (rapamycin)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20847709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/IAE.0B013E3181E7978E

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35215452&oldid=2204544533"